Auditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson’s Disease by Ali Soliman Shalash et al.
February 2017 | Volume 8 | Article 551
Original research
published: 27 February 2017
doi: 10.3389/fneur.2017.00055
Frontiers in Neurology | www.frontiersin.org
Edited by: 
Antonio Pisani, 
University of Rome Tor Vergata, Italy
Reviewed by: 
Tifei Yuan, 
Nanjing Normal University, China  
Graziella Madeo, 
National Institutes of Health (NIH), 
USA
*Correspondence:
Ali Soliman Shalash 
ali_neuro@yahoo.com; 
Oscar Arias-Carrión 
arias@ciencias.unam.mx
Specialty section: 
This article was submitted to 
Movement Disorders, 
a section of the journal 
Frontiers in Neurology
Received: 17 November 2016
Accepted: 07 February 2017
Published: 27 February 2017
Citation: 
Shalash AS, Hassan DM, 
Elrassas HH, Salama MM, 
Méndez-Hernández E, Salas-
Pacheco JM and Arias-Carrión O 
(2017) Auditory- and Vestibular-
Evoked Potentials Correlate with 
Motor and Non-Motor Features of 
Parkinson’s Disease. 
Front. Neurol. 8:55. 
doi: 10.3389/fneur.2017.00055
auditory- and Vestibular-evoked 
Potentials correlate with Motor and 
non-Motor Features of Parkinson’s 
Disease
Ali Soliman Shalash1*, Dalia Mohamed Hassan2, Hanan Hani Elrassas3,  
Mohamed Mosaad Salama4, Edna Méndez-Hernández5, José M. Salas-Pacheco5 and 
Oscar Arias-Carrión6*
1 Department of Neurology, Ain Shams University, Cairo, Egypt, 2 Audiology Unit, Department of Otorhinolaryngology, Ain 
Shams University, Cairo, Egypt, 3 Institute of Psychiatry, Ain Shams University, Cairo, Egypt, 4 Department of Toxicology, 
Mansoura University, Mansoura, Egypt, 5 Instituto de Investigación Científica, Universidad Juárez del Estado de Durango, 
Durango, Mexico, 6 Unidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Ciudad de 
México, Mexico
Degeneration of several brainstem nuclei has been long related to motor and non-motor 
symptoms (NMSs) of Parkinson’s disease (PD). Nevertheless, due to technical issues, 
there are only a few studies that correlate that association. Brainstem auditory-evoked 
potential (BAEP) and vestibular-evoked myogenic potential (VEMP) responses represent 
a valuable tool for brainstem assessment. Here, we investigated the abnormalities of 
BAEPs, ocular VEMPs (oVEMPs), and cervical VEMPs (cVEMPs) in patients with PD 
and its correlation to the motor and NMSs. Fifteen patients diagnosed as idiopathic 
PD were evaluated by Unified Parkinson’s Disease Rating Scale and its subscores, 
Hoehn and Yahr scale, Schwab and England scale, and Non-Motor Symptoms Scale. 
PD patients underwent pure-tone, speech audiometry, tympanometry, BAEP, oVEMPs, 
and cVEMPs, and compared to 15 age-matched control subjects. PD subjects showed 
abnormal BAEP wave morphology, prolonged absolute latencies of wave V and I–V 
interpeak latencies. Absent responses were the marked abnormality seen in oVEMP. 
Prolonged latencies with reduced amplitudes were seen in cVEMP responses. Rigidity 
and bradykinesia were correlated to the BAEP and cVEMP responses contralateral to 
the clinically more affected side. Contralateral and ipsilateral cVEMPs were significantly 
correlated to sleep (p =  0.03 and 0.001), perception (p =  0.03), memory/cognition 
(p = 0.025), and urinary scores (p = 0.03). The oVEMP responses showed significant 
correlations to cardiovascular (p =  0.01) and sexual dysfunctions (p =  0.013). PD is 
associated with BAEP and VEMP abnormalities that are correlated to the motor and 
some non-motor clinical characteristics. These abnormalities could be considered as 
potential electrophysiological biomarkers for brainstem dysfunction and its associated 
motor and non-motor features.
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inTrODUcTiOn
Parkinson’s disease (PD) is a common neurodegenerative disor-
der caused by degeneration of midbrain dopaminergic neurons 
of substantia nigra (SN) producing its primary motor cardinal 
features (1). In addition to the motor symptoms, PD patients 
develop a variety of non-motor symptoms (NMSs), which signifi-
cantly impair their quality of life. The NMSs consist of autonomic 
dysfunction, sensory symptoms, neuropsychiatric disturbances, 
sleep disorders, fatigue, and gastrointestinal disorders (2). Those 
NMSs are associated with dopaminergic and non-dopaminergic 
dysfunctions including serotoninergic, noradrenergic, and cho-
linergic systems (3, 4). Degeneration of several brainstem nuclei 
and their connections is responsible—at least partially—for dif-
ferent neurotransmitters disruption, resulting in different NMSs 
(3, 5).
Lewy bodies (LB) and Lewy neurites (LN) composed of 
alpha-synuclein are the pathological hallmarks of PD (6, 7). 
Alpha-synuclein pathology related to NMS was described in 
brain hemispheres, brainstem, spinal cord, and peripheral nerv-
ous system (5). Recent studies emphasized the importance of 
brainstem as the habitat of degeneration of nuclei responsible for 
different NMSs (8). Moreover, some NMS-related pathological 
changes might have specific distribution and anatomical localiza-
tion in various levels of the brainstem. For example, depression 
and REM sleep behavior disorder are related to degeneration of 
pontine nuclei (5).
These reports are consistent with Braak’s proposal of patho-
logical progression of PD, which starts caudally from the dorsal 
motor vagal nucleus in the medulla and then ascends in the brain-
stem and finally involves neocortex (9, 10). Thus, most brainstem 
nuclei are involved in early stages (I–III) that explain the preclini-
cal and early emergence of NMS, while SN is involved in stage III 
(3, 5). Recently, Seidel et al. demonstrated the widespread of LB 
and LN in brainstem nuclei and fiber tracts including vestibular 
nuclei (4). Therefore, diagnostic tools exploring disruption of 
lower brainstem nuclei and related NMS are needed for early 
diagnosis of PD (11).
Brainstem auditory-evoked potential (BAEP) and vestibular-
evoked myogenic potential (VEMP) responses represent a valu-
able tool for brainstem assessment as the neural pathways of both 
ocular VEMPs (oVEMPs) and cervical VEMPs (cVEMPs) pass 
through the brainstem (12). VEMPs are short latency manifesta-
tions of vestibulo-ocular reflex connecting VIII and III cranial 
nuclei and vestibulo-collic reflex connecting VIII and XI cranial 
nuclei that originate from the utricle and saccule, respectively (12). 
Previous studies described impaired BAEP and VEMP responses 
in PD patient compared to controls that were attributed to under-
lying brainstem dysfunction (13–16). Furthermore, impairment 
of these responses was related topographically to other brainstem 
lesions. Principally, the BAEP and oVEMP responses are affected 
in upper brainstem (midbrain) lesions, while cVEMP responses 
are involved in the lower brainstem (pontine and upper medul-
lary) lesions (17–19). Therefore, they have a localizing value of 
brainstem dysfunction at different levels.
In the current study, we hypothesized that NMSs of PD related 
to brainstem dysfunction could be related to changes in VEMPs 
and BAEP. Accordingly, the aim of this study was to explore the 
abnormalities of BAEPs and VEMPs in patients with PD and its 
correlation to the motor and NMSs of PD.
MaTerials anD MeThODs
Materials
Fifteen patients diagnosed as idiopathic PD and 15 age-matched 
control subjects were included in the current prospective study. 
PD patients were recruited from the movement disorders out-
patient clinic at Ain Shams University Hospitals, Cairo, Egypt 
in the period between 2013 and 2015. Recruited patients were 
diagnosed as idiopathic PD according to the British Parkinson’s 
Disease Society Brain Bank criteria (20). Exclusion criteria 
included dementia (MMSE score <24), improper neck move-
ments that interfere with audiological assessment, middle ear 
diseases, and hearing thresholds exceeding 50 dBnHL.
All subjects were evaluated using Unified Parkinson’s Disease 
Rating Scale (UPDRS), Hoehn and Yahr scale (H&Y), and Schwab 
and England scale (S&E) in “medication off ” and “on” states by 
a movement disorders expert. Different UPDRS subscales were 
estimated including the activity of daily living (UPDRS I), a motor 
(UPDRS III), UPDRS I, and total UPDRS scores. Furthermore, 
main motor symptoms subscores were calculated such as tremor 
(items 20 and 21 of UPDRS), rigidity (item 22), bradykinesia 
(items 18, 19, 23, and 24), axial signs (items 27, 28, 29, and 30), 
postural instability/gait disability score (items 13, 14, 15, 29, and 
30) (21). The NMSs were measured for all patients by the Non-
Motor Symptoms Scale (NMSS) administrated by the movement 
disorders expert (2). Control subjects were age- and sex-matched 
normal volunteers and provided a reference of auditory and 
vestibular work up. Informed consent was taken from all subjects 
before participation in the present study. The study protocol was 
approved by the Ethics Committee of Faculty of Medicine, Ain 
Shams University. All subjects gave written informed consent by 
the Declaration of Helsinki.
Procedures
Audio-Vestibular Works Up
Basic audiological evaluation to assess the peripheral auditory 
system, pure-tone (PTA), and speech audiometry was done 
using the two-channel audiometer Grason-Stadler Inc. (GSI, 
Eden Prairie, MN, USA) model 61 calibrated according to ANSI 
(1969) in a sound-treated room IAC model 1602 (IAC Acoustics, 
UK). The middle ear functions were tested through the acoustic 
immittance meter Grason-Stadler Inc. (GSI, Eden Prairie, MN, 
USA) model 33. BAEP and VEMP were done to all subjects of the 
study using the ICS Chartr EP 200—GN Otometrics (Denmark)-
evoked potential system.
For the BAEP assessment, the active electrode was mounted 
to the middle of the forehead “Fpz,” the reference electrode to 
the ipsilateral mastoid “M1,” and the ground to the contralateral 
one “M2.” The test procedures followed Sininger protocol (22). 
Analysis of BAEP was done quantitatively to assess the absolute 
latencies of waves I, III, and V and interpeak latencies of these 
waves (I–III, III–V, and I–V). This was done both at high stimulus 
level “90 dBnHL” and at lower intensities down to thresholds. The 
FigUre 1 | a sample of recorded response of cVeMP (a) and oVeMP (B) in one of study subjects. cVEMPs, cervical vestibular-evoked myogenic 
potentials; oVEMP, ocular VEMPs.
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interaural latency difference and the latency/rate function were 
studied at high stimulus intensity. Qualitative analysis of the 
waveform morphology comprised the subjective judgment on 
the shape and the quality of the waveforms.
Vestibular-evoked Myogenic Potentials
oVEMP Test
Monaural stimulation with contralateral eye recording was 
employed for recording oVEMPs (23). Three surface electromyo-
graphy (EMG) electrodes were placed on the face just inferior and 
at the center of lower eyelid (the active electrode), the chin (the 
reference electrode), and the forehead (the ground electrode). 
During recording, all subjects were instructed to look upward at 
a small fixed target >2 m from the eyes, while the vertical eye 
position was at an angle of approximately 30–35° above horizon-
tal. The oVEMP response included the initial negative–positive 
biphasic waveform comprised peaks n1 and p1. Two runs were 
performed for each test to confirm the reproducibility of results. 
The latencies of peaks n1 and p1, amplitude n1–p1, and interaural 
amplitude difference (IAD) ratio were measured.
cVEMPs Test
The subject was seated with the head rotating sideways toward 
one shoulder to activate the sternocleidomastoid (SCM) muscle. 
The active electrode was placed at midpoints of each SCM muscle 
on symmetrical sites, the reference electrode on the suprasternal 
notch, and the ground electrode on the forehead. Monaural 
acoustic stimulation with ipsilateral recording was employed for 
recording cVEMPs. The n13–p13 wave latencies, amplitudes, and 
IAD were measured (24).
Assessment of auditory and vestibular responses was done 
during medications “On” states to decrease EMG artifacts and 
ensure patients cooperation. The findings of BAEPs, cVEMPs, 
and oVEMPs of PD patients were grouped to ipsilateral and 
contralateral to the clinically more affected (CMA) side and 
compared to the mean of both sides of the control subjects, then 
VEMP responses are correlated to different UPDRS Off-scores 
and NMS scores. Figure 1 shows samples of cVEMP and oVEMP 
responses of one of the recruited subjects.
statistical analysis
Statistical analyses were performed using the SPSS version 18. 
Qualitative data were described using number and percent, while 
quantitative data were described using mean and SD. Association 
between categorical variables was tested using chi-square test. 
Comparison between two independent variables was done using 
independent t-test. Correlations between quantitative variables 
were assessed using Spearman coefficient. The level of statistical 
significance (p value) was set at 0.05 (significant) and 0.01 (highly 
significant).
resUlTs
Fifteen patients with idiopathic PD (12 males and 3 females) 
completed the clinical and audiological assessments. Their mean 
age was 59.20 ± 10.08 years (ranged from 35 to 70 years), and the 
duration of illness was 5.50 ± 2.96 years (2–10 years). The mean 
total UPDRS and mean disease disability (S&E scale) scores were 
41.33 ± 30.20 and 68.67 ± 22.30, respectively. Patients were of 
variable disease stages ranged from stage 2 to 5 of H&Y scale 
in “Off ” state with mean 2.73 ±  0.84. All patients had at least 
impaired domain of NMS. Sleep/fatigue (86.7%) and mood/cog-
nition (73.3%) were the most frequent reported NMS. Detailed 
motor and non-motor scores of the PD patients are presented in 
Tables 1 and 2.
audiological Work Up
The PD patients had significantly higher PTA thresholds mainly 
in the high frequencies 4 and 8 kHz bilaterally compared to the 
age-matched control group (p < 0.03). Seven PD subjects (46.7%) 
had sensorineural hearing loss of mild to moderate degree (bilat-
eral symmetrical in five and unilateral in two).
Brainstem Auditory-Evoked Potentials
The ipsilateral and contralateral absolute latencies of wave V 
(p = 0.04) and I–V interpeak (p = 0.025 and 0.03) latencies were 
significantly prolonged compared to controls. Moreover, the 
wave III and the interpeak I–III latencies were also significantly 
prolonged (p =  0.03 and 0.036, respectively) ipsilateral to the 
TaBle 2 | severity and prevalence of non-motor manifestations of 
Parkinson’s disease patients.
nMs Mean ± sD (range) Prevalence (%)
NMS CVS 0.93 ± 1.67 (0–6) 40
NMS sleep/fatigue 7.07 ± 6.36 (0–22) 86.7
NMS mood and cognition 11.60 ± 12.54 (0–42) 73.3
NMS perception/hallucinations 0.80 ± 1.27 (0–4) 33.3
NMS memory 5.00 ± 6.07 (0–20) 60
NMS GIT 2.80 ± 3.78 (0–9) 53.3
NMS urinary 5.87 ± 8.96 (0–33) 60
NMS sexual 3.93 ± 5.81 (0–16) 46.7
NMS miscellaneous 3.33 ± 4.67 (0–17) 60
NMS total 41.33 ± 30.20 (2–109) 100
NMS, non-motor symptoms; CVS, cardiovascular system; GIT, gastrointestinal tract.
TaBle 1 | Demographic and clinical characters of Parkinson’s disease 
patients.
clinical feature Mean ± sD (range)
Age (years) 59.20 ± 10.08 (35–76)
Duration of disease (years) 5.50 ± 2.96 (2–10)
Age of onset (years) 53.77 ± 11.49 (25–70)
H&Y off 2.73 ± 0.84 (2–5)
H&Y on 0.93 ± 0.59 (0–2)
S&E off 68.67 ± 22.30 (50–90)
S&E on 90.0 ± 9.26 (70–100)
UPDRS I off 3.33 ± 2.13 (0–6)
UPDRS II off 12.73 ± 7.49 (0–27)
UPDRS III off 30.20 ± 17.49 (2–69)
UPDRS IV 0.67 ± 1.40 (0–4)
UPDRS-total 41.33 ± 30.20 (2–109)
Postural instability/gait disability off 5.20 ± 4.06 (0–16)
Axial off 5.27 ± 4.28 (0–15)
H&Y, Hoehn and Yahr scale; S&E, Schwab and England scale; UPDRS, Unified 
Parkinson’s Disease Rating Scale.
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CMA side. Eight patients (53%) had an abnormal BAEP wave 
morphology.
Ocular VEMPs
Absent oVEMP responses were the commonest abnormality and 
were detected in 47% of PD subjects (n = 7). Compared to control 
group, the latencies of n1 and p1 were significantly prolonged 
when contralateral to the CMA side (p = 0.04 and 0.025), and 
n1–p1 amplitude was significantly reduced bilaterally (p < 0.001).
Cervical VEMPs
The cVEMP responses were absent in three patients (20%). 
Compared to controls, the ipsi- and contralateral p13, and con-
tralateral n23 latencies were significantly prolonged (p =  0.04, 
0.001, and 0.04, respectively) and bilateral p13–n23 amplitudes 
were significantly decreased (p < 0.001).
correlations between BaeP, VeMPs, and 
UPDrs scores
The contralateral absolute latencies of waves III and V were sig-
nificantly correlated to disease severity (H&Y scale) (r = 0.610, 
p =  0.028 and r =  0.530, p =  0.043, respectively) and wave V 
with rigidity “Off ” score (r =  0.540, p =  0.039). Furthermore, 
the absence of BAEP waves contralateral to the CMA was sig-
nificantly correlated to S&E, UPDRS III, and rigidity “Off ” scores 
(r =  0.665, p =  0.007; r = −0.540, p =  0.037; and r = −0.770, 
p = 0.001, respectively).
The abnormal cVEMP responses contralateral to the CMA 
side showed significant correlation to “H&Y” disease stage (wave 
latency) (r = 0.689, p = 0.013), UPDRS III (r = 0.523, p = 0.045), 
rigidity (wave latency) (r = 0.634, p = 0.027), and bradykinesia 
“Off ” scores (wave absence) (r = 0.571, p = 0.026). The ipsilateral 
p13 and n23 wave latencies were also correlated to dyskinesia 
scores (r = 709, p = 0.01 and r = 634, p = 0.027, respectively). 
Furthermore, the oVEMP responses ipsilateral to the CMA side 
showed moderate correlation with a trend to significance with 
UPDRS III, rigidity, and axial “off ” scores (p = 0.046, 0.05, and 
0.049, respectively).
On the other hand, the UPDRS II, tremor, and S&E subscales 
showed no significant correlations with BAEP and VEMP 
responses. The duration of the disease, age, and age of onset 
showed no correlation either with BAEP, cVEMP, and oVEMP 
responses.
correlations between BaeP, VeMPs, and 
non-Motor scores
The BAEP showed minor associations to some non-motor func-
tions scores. The contralateral I–III and I–V interpeak latencies 
were correlated to NMS-gastrointestinal tract (GIT) scores 
(r = 0.625, p = 0.03 and r = 0.595, p = 0.041, respectively), while 
the ipsilateral I–III interpeak latency was correlated to sleep/
fatigue scores (r = 0.586 and p = 0.035).
Contralateral and ipsilateral cVEMP responses showed 
significant correlations to most of NMSS domains. They were 
significantly correlated to mood/cognition (0.024), sleep/
fatigue (p =  0.03 and 0.001), perception (p =  0.03), memory 
(p = 0.025), and urinary scores (p = 0.03). Sexual dysfunction 
was moderately correlated to the absence of ipsilateral responses 
(p = 0.045). The oVEMP responses showed significant correla-
tions to fewer NMS domains including NMS cardiovascular 
system (p = 0.01), sexual dysfunction (p = 0.013), and percep-
tion (moderate correlation, p = 0.047) (see Table 3; Figure 2). 
GIT domain showed no significant correlation with VEMP 
responses.
DiscUssiOn
The current study investigated comprehensively the brainstem 
dysfunction of PD patients and its relation to motor and NMSs 
using BAEPs and VEMPs. It confirmed the impairment of BAEP 
and VEMP responses in patients with PD compared to controls 
that are related to clinical asymmetry of PD and its cardinal 
motor features. The BAEPs and cVEMPs were correlated signifi-
cantly to contralateral motor UPDRS, rigidity, and bradykinesia 
severity, and ipsilateral dyskinesia scores. Moreover, cVEMP 
responses were correlated to some non-motor features including 
sleep/fatigue, mood/cognition, perception, and memory. BAEP 
and oVEMP responses showed less correlation to the motor and 
FigUre 2 | The schematic diagram describes the topographic distribution of different motor and non-motor manifestations of Parkinson’s disease 
patients according to its correlation with BaeP, cVeMP, and oVeMP abnormal responses in the current study. BAEPs, brainstem auditory-evoked 
potentials; cVEMPs, cervical vestibular-evoked myogenic potentials; oVEMP, ocular VEMPs.
TaBle 3 | Positive correlation between nMs scores and VeMP 
responses.
nMs related arB and vestibular-evoked 
myogenic potential (VeMP) responses
r p
CVS Contralat ocular VEMPs (oVEMP) absent 
response
−0.643 0.01
Sleep/fatigue Ipsilat I–III 0.586 0.035
Contralat cervical VEMPs (cVEMPs) n23 
latency
0.845 0.001
Contralat cVEMP p13 latency 0.583 0.047
Ipsilat cVEMP pn amplitude −0.625 0.03
GIT Contralat I–III latency 0.625 0.03
Contralat I–V latency 0.595 0.041
Mood/cognition Contralat cVEMP n23 latency 0.643 0.024
Perception/
hallucination
Ipsilat cVEMP pn amplitude −0.625 0.03
Contralat oVEMP p1 latency 0.674 0.047
Memory Contralat cVEMP pn amplitude −0.639 0.025
Urinary Ipsilat cVEMP n23 latency 0.622 0.031
Sexual Contralat oVEMP n1 latency 0.782 0.013
Ipsilat cVEMP absent response 0.524 0.045
NMS, non-motor symptoms; CVS, cardiovascular system; GIT, gastrointestinal tract; 
Ipsilat, ipsilateral; contralat, contralateral (to clinically more affected side).
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non-motor features. Consequently, it reflects brainstem pathol-
ogy among PD patients at different levels and highlights the 
asymmetry of these changes.
In this study, we separated the vestibular responses to ipsi-
lateral and contralateral responses according to CMA side. This 
approach could reflect the expected asymmetrical brainstem 
pathology of PD (25). Previous studies confirmed the asymme-
try of cardinal motor symptoms that often persists through the 
course of the disease. This clinical asymmetry is related to asym-
metrical degeneration of dopaminergic neurons of SN, striatal 
dopaminergic receptors, and their cortical connections (8, 25). 
Furthermore, the clinical asymmetry could be related to NMSs 
including pain, fatigue, depression, and cognitive dysfunction. 
This could be explained by asymmetrical underlying pathologi-
cal changes and the asymmetrical dopaminergic deficiency that 
contributes to some non-motor features along with other neuro-
transmitters (8, 25).
The high-frequency hearing impairment associated with PD 
was detected in the current work similar to prior studies (26–28). 
Impaired hearing in PD was attributed to peripheral auditory 
dysfunction (27, 28) and abnormal central auditory processing 
(29, 30). Likewise, abnormal BAEPs among PD patients were 
demonstrated inconsistent to previous studies, denoting brain-
stem auditory conduction delay (26, 31, 32).
Additionally, both the oVEMPs and cVEMPs were affected in 
the studied PD subjects. The findings of the present study agreed 
with de Natale et al. who reported that the frequency of altera-
tion of VEMPs in PD patients was 83.3% when considering the 
6Shalash et al. Evoked Potentials Correlate PD Features
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combined set of cVEMP, oVEMP, and masseter VEMP responses, 
with absence being the prevalent alteration in PD (14). Similarly, 
Pollak et  al. showed unilaterally absent VEMP responses in 20 
(37%) of PD patients and bilaterally absent responses in 4 patients 
(7.4%) (33). Lower amplitudes of cVEMPs among PD patients 
were reported by another study (34). However, a recent study by 
Pötter-Nerger et al. reported abnormal oVEMPs in mild to mod-
erate PD patients with preserved cVEMPs that were attributed 
to methodological differences (16). These findings emphasize 
the extensive brainstem dysfunctions at different anatomical 
levels (35).
Auditory and vestibular dysfunctions in PD could be 
explained by different mechanisms. Modulatory effect of 
dopamine on the excitability of vestibular nuclei is one of these 
mechanisms (34). Disrupted interconnections of vestibular 
nuclei with degenerated other brainstem nuclei by PD pathol-
ogy especially dorsal raphe nuclei is another mechanism (36, 
37). Furthermore, direct disruption of vestibular nuclei by PD 
pathological changes produces these vestibular abnormalities as 
recently reported (4).
Remarkably, the current study defined correlation of the 
main motor features of PD with BAEPs and cVEMPs rather 
than oVEMPs that might be explained by the midbrain and 
pontine pathological changes and non-involvement of vestib-
ulo-ocular pathways in the pathophysiology of these features. 
Rigidity and bradykinesia were related to BAEP and cVEMP 
responses, while tremor was not. The correlations were mainly 
to the responses contralateral to CMA side, which is consist-
ent with asymmetric nature of PD pathology in SN and their 
connections (25).
Tremor has different pathophysiology compared to rigid-
ity and bradykinesia and characterized by involvement of the 
cerebellum–thalamocortical circuit in its pathogenesis (37). 
This explains the lack of correlation with auditory and vestibular 
responses. Moreover, recent animal studies demonstrated that 
brainstem structures such as pontine nuclei and locus coeruleus 
are involved in the pathophysiology of levodopa-induced dyski-
nesia (LID) (38). This could explain the correlation seen in the 
present study between LID and cVEMP wave latencies.
Although the correlation of BAEPs, oVEMPs, and cVEMPs 
were mainly to one side, yet no differences existed in all tests 
between the two sides. The medication state of the subjects 
could be the explanation. All PD subjects underwent the tests 
during “medication on state” that masked the abnormalities 
between the two sides as recently reported by Pötter-Nerger 
et al. (34).
In contrast, previous studies reported a lack of correlation 
with clinical motor scores (14, 33, 34). Nonetheless, de Natal 
et  al. defined the progression of VEMP abnormalities with 
increased stage of the disease (14). They used the mean values 
of VEMP responses on both sides, not about the CMA side, thus 
underestimating the potential asymmetry that could ameliorate 
abnormalities. Moreover, differences in experimental conditions 
during testing, age differences between cases and controls, and 
different clinical characteristics of recruited patients could explain 
the inconsistency of results of different studies that addressed the 
vestibular functions in PD.
Few prior studies investigated the correlation of auditory 
and vestibular responses with individual NMSs of PD (14, 33). 
In the current study, sleep and mood domains’ severity demon-
strated correlation with cVEMP responses that could be related 
to associated dysfunction of different pontine nuclei such as 
locus coeruleus, raphe nucleus, and pedunculopontine nucleus 
(3). Previous studies reported localizing function of cVEMP 
responses of pontine lesions associated with different other 
diseases (17–19). Recently, de Natale et al. found a direct correla-
tion between VEMP changes and REM sleep behavior disorder 
and postural instability (14). The same study reported a lack of 
correlation with depression (14), while a study by Pollack et al. 
reported a correlation of cVEMP with depression and antidepres-
sants use (33).
Unsurprisingly, GIT domain that includes hypersalivation, 
dysphagia, and constipation had minor correlations. This could 
be attributed to the high contribution of peripheral pathological 
changes in GIT and related nerve supply (alpha-synucleinopathy) 
along with brainstem changes (39–41). Furthermore, GIT 
symptoms are attributed to dysfunction of the dorsal motor 
nucleus of the vagus, nucleus ambiguous, and nucleus of a 
solitary tract located in the medulla (3) that is poorly localized 
by VEMP responses (13). Correlation of GIT symptoms’ severity 
to contralateral BAEP latency could be explained by associated 
advanced disease (42). Similarly, the contribution of sacral spinal 
cord alpha-synuclein deposition to urinary symptoms explains 
limited correlation to vestibular responses (43). Likewise, correla-
tion of other non-motor features poorly linked to brainstem dys-
function such as cardiovascular symptoms, attention/memory, 
and perception/hallucination could be explained by associated 
disease severity (42). Cognitive deficits of PD are correlated to 
higher order auditory processing in subcortical–cortical path-
ways evaluated by event-related potentials (P300) (29, 44).
The current study has different limitations. These limitations 
include a small number of recruited sample, including patients 
with different disease severity and stages, and the use of NMSS 
subscores that describe different NMSs for correlations with 
vestibular responses. Thus, further, more specific tools for each 
NMS are required for correlation with the electrophysiological 
assessment of the larger number of PD patients.
In conclusion, the current study confirms the auditory and 
vestibular abnormalities among PD patients that reflect brain-
stem pathological changes. It also correlates these abnormalities 
to some motor and non-motor features of the disease, providing a 
localizing tool for associated brainstem dysfunction. Furthermore, 
abnormal vestibular potentials are related to disease severity and 
stage and might respect clinical and pathological asymmetry. 
However, further studies are warranted to reproduce the correla-
tion of VEMP responses to the individual motor and NMSs of PD 
and their value as potential biomarkers at different stages of the 
disease, especially the early PD.
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